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ABSTRACT: The osteoblastoma is a benign primary tumor of 
the bone that is comprehended 1% of these kinds of tumors. It 
affects young individuals, mainly in the vertebral column, where 
it produces varied symptomatology, from pain to structured 
deformities, where the duration of symptoms until the definitive 
diagnosis is prolonged. The treatment is eminently surgical. It 
predominates in young males, about 3:1. This report describes 
a case of an expansive vertebral lesion in the T6 vertebra, with 
delimited margins, causing discrete expansion of the bone in a 
24-year-old male patient. The magnetic resonance imaging of 
the spine revealed the presence of a tumor larger than a lime 
orange at the T6 vertebra. Many bone-producing lesions have 
clinical features, especially neurological and radiological. It 
concludes that it is extremely important to understand all these 
findings, since it helps in the proper diagnosis to lead to the 
treatment of this rare injury, leading to a good prognosis.
Keywords:Osteoblastoma; Dorsal spine; Tumor; Male; T6 
vertebra.
RESUMO: O osteoblastoma é tumor benigno primário do osso 
e corresponde a 1% destes tumores. Acomete indivíduos jovens, 
principalmente na coluna vertebral, onde produz sintomatologia 
variada, desde dor até deformidades estruturadas, onde a 
duração dos sintomas até o diagnóstico definitivo é prolongada. 
O tratamento é eminentemente cirúrgico. Predomina nos jovens 
do sexo masculino, cerca de 3:1. Este relato descreve um caso 
de uma lesão vertebral expansiva na vértebra T6, com margens 
delimitadas, causando expansão discreta do osso em um 
paciente do sexo masculino de 24 anos de idade. A ressonância 
magnética da coluna vertebral revelou presença de um tumor 
com tamanho maior que uma laranja lima a nível de vértebra 
T6. Muitas lesões produtoras de osso possuem características 
clínicas, especialmente neurológicas e radiológicas. Conclui-se 
que compreender todos esses achados é de extrema importância, 
uma vez que auxilia no diagnóstico adequado para levar ao 
tratamento deste raro dano, levando a um bom prognóstico.
Palavras-chave: Osteoblastoma; Coluna dorsal; Tumor; Sexo 
masculino; Vértebra T6.
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INTRODUCTION
Osteoblastomas are benign neoplasms that arise from osteoblasts. They are uncommon 
lesions, accounting for less than 1% of bone tumors1,2,3,4,5. 
The most frequently affected bones are the spine, sacrum, 
calvaria, the longer bones, and small bones of the hands 
and feet. Osteoblastoma has a rapid clinical progression 
and is characterized by pain and swelling at the lesion 
site. The use of salicylates is associated with relief of 
painful symptoms. The lesions vary from 2 to 4 cm, but 
large lesions with about 10 cm can also be found2,3,4,6.
A primary tumor in the spine is rare. An early 
diagnosis of this lesion is usually difficult, as pain, 
functional limitation and deformity are common 
complaints in other spinal disorders. This tumor is more 
frequent in males (3:1) and is usually located in the 
posterior arch of the vertebrae7.
From a histological point of view, osteoblastomas 
have a large number of osteoblasts, in a highly vascularized 
tissue, interspersed with bone trabeculae with osteoid7. 
The treatment of osteoblastoma is mainly complete 
excision of the lesion or curettage. Osteoblastoma may be 
a reactive process, as there are reports of regression after 
biopsy or incomplete removal. The prognosis is good and 
recurrence and malignancy is rare2,4,5. This study aims to 
report the clinical case of a benign osteoblastoma in the 
T6 vertebra leading to motor impairment of the patient, 
with significant size, rapid growth and surgical treatment.
METHOD
A 24-year-old male patient had an osteoblastoma 
and presented a reduction in malignant cells after a 
surgical procedure.
CASE REPORT
A man has been complaining of spinal pain for 
2 years and visiting the hospital in moments of acute 
pain. Simple radiographic examinations did not show 
any changes. The patient reported using analgesics and 
muscle relaxants to relieve pain. One day, he woke up with 
paresthesia on his left hallux and a “lump on his back” 
that grew rapidly every day, reaching the entire left lower 
limb and the right foot. He then went to an orthopedist 
who requested a sagittal view of the magnetic resonance 
imaging of the thoracic spine. The exam showed a tumor 
of approximately 6 cm in diameter in the T6 vertebra 
(Figures 1 and 2).
The day after the consultation, January 16, 
2018, the patient was admitted to the State Emergency 
Hospital of the Northwest Region of Goiânia Governador 
Otávio Lage de Siqueira (HUGOL).  During a 15-day 
waiting period, the patient was administered intravenous 
tramadol hydrochloride 50 mg/mL due to severe pain, 
and the doctor ordered a biopsy. The patient already had 
paresthesia at the umbilical level and on both lower limbs, 
clonus only during the preoperative period, spasticity and 
hypoesthesia.
After these 15 days he was submitted to the surgical 
procedure without the result of the biopsy. The medical 
board decided not to wait, as the patient’s condition 
worsened every day. The surgery lasted 10 hours and 
was conducted by 14 doctors. The procedure performed 
was the resection of the vertebrae T6 with vertebrectomy 
and arthrodesis and fixation of the vertebrae via T3-T9 
(Figure 3). In the postoperative period, the patient had 
a pleural effusion, but drainage was not necessary. The 
patient spent a night in the Intensive Care Unit (ICU).
Figure 1: Sequence of the progression of the osteoblastoma in the patient studied
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Figure 2: Sequence of the osteoblastoma developed in the T6 vertebra
Figure 3: Vertebrectomy and arthrodesis via T3-T9 vertebrae.
The left lower limb did not have any sequelae, but 
the right lower limb was the most affected after surgery, 
with hypoesthesia and spasticity. On the physical therapy 
evaluation, 8 days after surgery, the patient initially 
reported loss of trunk control and muscle strength and 
altered sensitivity. As for the classification of the injury, 
the patient had a functional level at T6, ASIA C1818 with 
the following classification of muscle strength: 
Right upper limb: C5 G5, C6 G5, C7 G5, C8 G5, T1 G5;
Left upper limb: C5 G5, C6 G5, C7 G5, C8 G5, T1 G5;
Left lower limb: L2 G4 / L3 G5 / L4 G3 / L5 G3 / S1 G3;
Right lower limb: L2 G2 / L3 G5 / L4 G3 / L5 G3 / S1 G3.
In the neuromuscular evaluation, the patient 
reported spasms in the lower limbs. Clonus or hyperreflexia 
612
Silva GAD, et al. Osteoblastoma in dorsal spine: case report 
were not observed. The patient did not have contractures 
or deformities and the movement of the lower limbs 
was preserved, but there was muscle strength deficit and 
bilateral dorsiflexion. As for locomotion, the patient was 
unable to walk, so he used a wheelchair and needed the 
help of someone else. The patient also reported he needed 
visual stimulus to be able to walk.
Gait analysis revealed a proprioception deficit. On 
physical examination, muscle strength and skin sensitivity 
in the lower limbs were normal. Proprioception and 
Romberg tests were positive. The kinematic assessment 
showed compensations for slow and cautious gait: 
excessive anterior pelvic tilt and reduced pelvic motion 
in the other planes of motion, inadequate hip extension 
and reduced coronal plane range of motion, absence of 
knee flexion with bilateral hyperextension and greater 
flexion in the right side and reduced ankle movement on 
both sides.
Thus, doctors prescribed the use of orthoses and 
the use of a vest for 3 to 6 months, for complete spinal 
immobilization. However, this was not necessary, as 
within 1 week the patient started physical therapy 
and presented significant improvement. The result of 
the biopsy revealed few malignant cells, so radio- or 
chemotherapy were not necessary.
Currently, the patient has level 5 muscle strength 
in most muscles (5- normal muscle strength; 4≤ - muscle 
strength altered in relation to gravity and resistance) 
and weakness in the gluteal muscles, tibia and fibula, 
improvement of balance and proprioception, and has 
progressed to home walking with the aid of a walker 
and supervision. The patient goes to physical therapy, 
hydrotherapy and visual biofeedback sections at the CRER 
– Rehabilitation and Readaptation Center Dr. Henrique 
Santillo and has achieved significant improvement in gait. 
He uses Baclofen 10mg every 6 hours to decrease muscle 
spasticity.
DISCUSSION
This study presented the report of a case of 
osteoblastoma, with complaints of paresthesia and 
hypoesthesia, confirming the association between 
neurological dysfunction and the osteoblastoma studied. 
However, it is known that osteoblastomas have more 
common clinical manifestations and neurological 
problems7.
In the case presented, the individual was 24 
years old, meaning he was part of the risk group for the 
development of bone neoplasms. This is in accordance 
with the literature, which reports that one of the 
characteristics of this bone tumor is affecting individuals 
between 20 and 30 years of age8.
According to the literature, 25% of the cases in 
which patients had imaging exams (radiography and 
resonance), the presence of a mass was diagnosed as 
malignant osteoblastoma9. Given the above, the imaging 
examination of the case studied here suggested a bone 
mass at the level of T6, confirming a benign osteoblastoma.
In the preoperative phase, the patient used 
intravenous tramadol hydrochloride 50 mg/mL for pain 
relief. This medication is indicated for moderate to severe 
pain relief (analgesia), regardless of the type of pain10,11.
In the postoperative period, the patient did not 
have to use the orthoses or the vest, as physical therapy 
with gait training exercises and strengthening of the spine 
was enough to guarantee a progressive improvement in 
gait. This is in line with the literature on physical therapy 
in the postoperative period of arthrodesis, which includes 
therapeutic exercises, gait training, active and passive 
stretching, postural re-education, strengthening of the 
spine and instructions on activities of daily living to 
protect the fixation site12,13,14.
The patient continues to use Baclofen 10mg every 
6 hours to decrease muscle spasticity, which contributes 
to the improvement of gait. Baclofen is the first treatment 
option and the one with the fewer side effects for reducing 
spasticity in cases of spinal cord injuries15,16.
Benign bone-forming tumors in the spine are 
uncommon. However, they can cause spinal deformity, 
severe pain and neurological changes such as paresis, loss 
of trunk control and loss of muscle strength, most often in 
young males. The clinical presentation of osteoblastoma 
is aggressive and there is a high possibility of neurological 
deficit at the initial examination. The persistence of pain 
is a strong indication of residual tumor due to incomplete 
resection, while the return of pain suggests disease 
recurrence.
CONCLUSION
This study has demonstrated that the definitive 
treatment must be surgical, with complete resection of the 
tumor. It was found that neurological injuries are more 
common in patients with a narrower vertebral canal that 
meets the spinal cord. As the disease progresses, there 
can be damage to the growth plate and degeneration or 
fibrosis of the paravertebral muscles.
The neurological recovery rate is 80 to 100% and 
physical therapy is indicated in 85% of cases17. In the case 
described here, the patient shows significant improvement 
in his physical and neurological condition. It is concluded 
that osteoblastoma is a rapidly progressive tumor that 
compromises the physical and psychological state of the 
patient, and its treatment is only surgical.
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